{"title":"As bird flu spreads in cows, US close to funding Moderna’s mRNA H5 vaccine","link":"https://arstechnica.com/?p=2027678","date":1717079321000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2024/05/bird-flu-800x546.jpg\" alt=\"Testing for bird flu, conceptual image\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2024/05/bird-flu.jpg\">Enlarge</a> (credit: Digicom Photo/Science Photo Library via Getty)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>The US government is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine, hoping to bolster its pandemic jab stockpile as an H5N1 outbreak spreads through egg farms and among cattle herds.</p>\n<p>The federal funding from the government’s Biomedical Advanced Research and Development Authority, known as BARDA, could come as early as next month, according to people close to the discussions.</p>\n<p>It is expected to total several tens of millions of dollars and could be accompanied by a commitment to procure doses if the phase-three trials are successful, they said.</p></div><p><a href=\"https://arstechnica.com/?p=2027678#p3\">Read 9 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=2027678&amp;comments=1\">Comments</a></p>","author":"Financial Times","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"db47b29f01ffd63458e407cadeaec3a038f1ac0c67a596b360d008733117ab71","category":"Tech"}